Peter Radovich - 04 Mar 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
04 Mar 2025
Net transactions value
-$676,928
Form type
4
Filing time
05 Mar 2025, 16:28:19 UTC
Previous filing
04 Feb 2025
Next filing
18 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale $623,458 -13,681 -51% $45.57 13,280 04 Mar 2025 Direct F1
transaction MIRM Common Stock Sale $53,470 -1,169 -8.8% $45.74 12,111 04 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average sale price for the transaction reported was $45.571143, and the range of prices were between $45.50 and $45.88. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.